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Objective: To test a case-definition score for its usefulness in the diagnosis of pulmonary aspergillosis and to  determine 
microbiological criteria useful in assessing the significance of isolating Aspergillus species from lower respiratory tract 
specimens (LRTS). 
Methods: With the exception of cystic fibrosis patients, all patients with Aspergillus isolated from LRTS were classified 
according to a clinical case-definition ratio as: (i) colonized patients; (i i) patients with isolates of undetermined 
significance; (iii) patients with proven or probable pulmonary aspergillosis. Retrospective review of pathology records 
led to  the identification of additional patients with histologically compatible pulmonary aspergillosis. Microbiological 
variables were compared between aspergillosis and colonization groups. 
Results: Seventy-six isolates of Aspergillus species were obtained from 73 patients. For patients with proven (n=2) or 
histologically compatible pulmonary aspergillosis (n=5) ,  the case definition ratio was always higher than 0.3 ; no patient 
with proven disease was classified into the colonized group. Compared to  patients considered to be colonized (n=26),  
patients with proven or probable pulmonary aspergillosis showed a significant difference in the total number 
of Aspergillus colonies cultured per episode. In addition, for bronchoalveolar lavage specimens, the mean number of 
Aspergillus colonies/agar plate was also significantly higher in the latter group. The sensitivity and specificity of 
Aspergillus spp. detection by culture of LRTS for proven or probable pulmonary aspergillosis was 35.7% and 70.4%, 
respectively. 
Conclusion: The case-definition ratio used in this study helps interpret the clinical significance of Aspergillus isolated 
from LRTS. Data for assessment should include the absolute number of colonies recovered from culture of any LRTS 
and, for bronchoalveolar lavage, the mean number of Aspergillus colonies per agar plate. 
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INTRODUCTION 
Fungal spores of  A x p q i l l i r s  species are widely 
distributed and about 1.50 cpecies of  Aspqillcrs are 
known [ l ] .  Aspc@llris species are the second most 
coninion fungi isolated from clinical specimens after 
Cairdida specie5 [2]. Isolation of Aspeyilliis colonies 
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from culture of lower respiratory tract specimens 
(LRTS) could represent either colonization, allergic 
bronchopuliiionary aspergdlosis, aspergillonia or invasive 
pulmonary aspergillosis [3].  No definite micro- 
biological nor clinical criteria have been proposed for 
interpreting the clinical significance of A.spegi//t/x 
species isolated from clinical specimens in previous 
studies 14-71, The only ‘iccepted definite diagnostic 
criteria of  invasive pulmonary aspergillosis are the 
demonstration of  filamentous nivceliuni in a histo- 
logical specimen, associated with a pocitive culture for 
A s p q i l h s .  Invasive disease should be recognized and 
treated early, AS it is a major cause of  morbidity and 
mortality in iiiiiiiunocomproniised patients [8.Y] and 
has also been reported in non-immunocomprorriised 
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non-neutropenic patients [ 101. However, early diag- 
nosis is difficult. Although fever and a new pulmonary 
infiltrate on chest X-ray in immunosuppressed patients 
unresponsive to antibiotics are highly suggestive of 
invasive aspergillosis, histological diagnosis is rarely 
possible as most of the neutropenic patients are also 
thrombocytopenic, contraindicating biopsy. In immuno- 
competent patients, interpreting the significance of an 
Aspergillus isolate is even more difficult as, in the vast 
majority of the cases, patients are colonized or may 
have another form of pulmonary aspergillosis. [ 3 ] .  
Thus, a case-definition scoring system should help 
both clinicians and clinical microbiologists to interpret 
the significance of Aspergillus colonies isolated from 
LRTS and could provide standardized criteria for 
diagnosis useful in therapeutic trials of invasive pul- 
monary aspergillosis. In the first phase, we tried to 
develop a case-definition ratio on a retrospective basis, 
as described in this paper. The accuracy of this scoring 
system will be further adapted and prospectively tested. 
M ETH 0 D S 
All Aspergillus positive LRTS cultures obtained over a 1 
year period were analyzed retrospectively in relation 
to the clinical form of aspergillosis present. All 
filamentous fungi isolated from culture in our clinical 
microbiology laboratory are routinely listed in a 
register. From this list, the work-sheet for the LRTS 
from which Aspergillus colonies were isolated could be 
found in the laboratory’s archives. Microbiological data, 
such as inoculated plates, number of Aspergillus colonies 
seen on each plate and delay in growth, were extracted 
from these work-sheets. 
The following information was recorded from the 
patients’ charts: demographic data, symptoms, signs, 
radiographic findings, risk factors, treatment (especially 
antifungal, other anti-infective and immunosuppressive 
therapy), histology results (biopsy and/or autopsy), 
impact of Aspetgillus recovery on clinical management, 
comment about Aspergillus isolation and outcome. 
With the exception of cystic fibrosis patients, all 
patients with Aspergillus isolated from LRTS were 
classified into three groups, according to a clinical case- 
definition ratio (Table 1): (i) ratio 10.3: colonized 
patients; (ii) ratio >0.3 and <0.5: patients with an 
Asppe~qillus isolate of undetermined significance; (iii) 
ratio 20.5: patients with proven or probable pul- 
monary aspergillosis. Patients with a ratio 20.75 were 
considered as belonging to the ‘high probability’ 
subgroup. The ratio was defined as scored points 
divided by the maximum possible points. A case was 
considered as proven pulmonary aspergillosis in the 
presence of regular filamentous septate hyphae in a 
Table 1 Case-definition questionnaire 
Ratio = scored points/maximum possible points 
Parameters: Points 
2 50% of the following assessable symptoms 
fever, cough, sputum production, dyspnoea, 
pleuritic pain, abnormal auscultation, respiratory 
rate 220/min 
non-specific radiological findings such as lung 
or signs: 1 
infiltrate or opacity on chest X-ray, CT or MRI 1 
or 
specific findings such as halo sign, air crescent, 
pleural location 2 
antifungal treatment effective against Arpergillus 
no improvement after 2 5 days of antibiotics 
1 
1 
1 no other etiology to the pulmonary symptomatology 
mild immunosuppression (corticosteroids, 
and/or neutropenia (< 1000 PMN/mm3) 
severe immunosuppression (OKT3, high dose 
steroids), 2 
and/or severe neutropenia (< 100 P M N / m 3 )  
cyclosporin), 1 
or 
Maximum possible points 8 
histological specimen, associated with a positive culture 
for Aspergillus sp., or with a positive blood culture. 
Pathology records reviewed retrospectively during the 
same one-year period led to the selection of additional 
patients with histology compatible with pulmonary 
aspergillosis in the absence of culture. The case- 
definition ratio was calculated for all patients with 
proven or histologically compatible aspergillosis in 
order to assess the accuracy of this scoring system. 
Criteria in the case-definition ratio included the 
presence of clinical and/or radiological signs of 
pulmonary involvement, the absence of improvement 
on antibiotic treatment, the absence of other pul- 
monary disease, effect of antifungal treatment and host 
factors (Table 1). These criteria were adapted from 
those used for inclusion of patients in different clinical 
trials [ll-211. In order to reduce the assessment bias 
due to the retrospective nature of the study, a ratio was 
preferred to a simple scoring scale. Patients with 
unavailable or very incomplete medical charts (less than 
5 individual criteria assessable) were excluded. 
The mean number of positive samples for 
Aspergillus on culture, proportion of positive agar plates, 
delay in growth, mean number of Aspergillus colonies/ 
episode for one particular patient (regardless of the 
number of samples cultured) and mean number of 
Aspergillus coloniedagar plate were compared in both 
aspergillosis and colonization groups. The clinical impact 
of culture results was also analyzed. 
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Statistical analysis 
The Mantel-Haenzel method was generally used to 
calculate Chi-squares and p-values. Two-tailed p-value 
calculated with Fisher’s exact test was preferred when- 
ever an expected value was less than five. Generally, 
cornparison of nieans was done by analysis of variance, 
which is equivalent to a Student’s t-test for two samples. 
If the two variances differed significantly, Satterthwaite’s 
method was used to compare the two means. For 
microbiological data, the Mann-Whitney two-tailed 
method was used; for clinical data, the two-tailed t-test 
was used. 
In the year studied, 76 strains ofArpergillus were isolated 
from LRTS from 73 patients. Aspetgillus furnijptus was 
the commonest species isolated (80%). A.  glaucus, 
which is a common environmental organism and a rare 
pathogen was isolated three times; once from a patient 
with aspergilloma and twice from patients without 
Aspeyillus-related pulnionary disease. Seventeen cystic 
fibrosis patients were excluded. Fourteen patients with 
incomplete or unavailable medical charts were not 
evaluated. Of the 42 remaining patients, 26 were 
classified into the colonized group, eight into the 
undetermined significance group, and eight in the 
aspergillosis group. O f  the eight patients placed in the 
proven or probable aspergillosis group, based on a ratio 
of 2 0.5, five were in the high-probability group (ratio 
2 0.75). Of  those, two suffered from proven invasive 
pulmonary aspergillosis, confirmed by the presence of 
regular filamentous septate hyphae on histology, and 
one suffered from aspergilloma. Thus, only two patients 
without disease proven to be due to Aspetgillus were 
classified into the high-probability group (ratio 2 0.75). 
One leukaeniic patient with chemotherapy-induced 
agranulocytosis presented with persistent fever, cough, 
dyspnoea, an infiltrate on chest X ray and was treated 
with itraconazole 24 hours before death on the basis 
Table 2 Accuracy of the case-definition questionnaire 
of A r p e ~ i l l r t s  being recovered from LRTS. A lung 
transplant patient, presenting with cough, dyspnoea 
and an infiltrate on chest X-ray, was treated with 
itraconazole after the recovery of Aspetgillus from a 
bronchoscopic specimen and had a successful outcome. 
Among the three remaining patients placed in the 
proven or probable aspergillosis group (ratio 2 0.5), 
two presented with cough and fever, unresponsive to 
antibiotics and low dose oral steroids. One improved 
after combined treatment with cyclophosphamide and 
high dose steroids for Wegener’s lung disease and the 
other improved after lobectomy for multiple bronchial 
stenoses, suggesting in both cases a pulmonary vasculitis. 
The last patient, treated for COPD with inhaled steroids 
for many years and with antibiotics for 15 days, 
presented with fever, cough, dyspnoea and infiltrate on 
lung X-ray, which resolved during hospitalization. All 
three patients had a favourable outcome without anti- 
fungal treatment. 
Five additional patients with histology compatible 
with pulmonary aspergillosis, but without culture 
confirmation of Aspergillus (four without culture and 
one with a negative culture), were identified by retro- 
spective analysis of pathology records. Thus, a total of 
seven patients had histology compatible with invasive 
pulmonary aspergillosis; five would be placed in the 
aspergillosis group (ratio 20.5), two in the undeter- 
mined significance group (ratio <0.5 and >0.3) and 
none in the colonization group (ratio 5 0.3) (Table 2). 
One additional patient, also identified by retro- 
spective analysis of pathology records, was operated on 
for an aspergillonia (compatible histology, but no 
culture done). Thus, from a total of 48 evaluable 
patients, three were suffering from aspergilloma (two 
Aspergillus culture positive). Despite the fact that the 
case-definition ratio was designed for invasive pul- 
monary aspergillosis and not for aspergilloma, none of 
the three patients with aspergilloma would have been 
classified into the colonization group. Thus, for 10 
patients having documented pulmonary involvenient 
Categories based on case-definition ratio 
Asprrgdlosis Undetermined Colonized 
Total 
Invasive pulmonary aspergillosis 2 + (3)  0 + (2)  I) 2 + (5) 
Aspergilloma 1 + (1) 1 0 2 + (1) 
No i l s p e ~ q i l l w  diseaac > 7 26 311 
Total + (4) 8 + ( 2 )  2 h 42 + (6) 
In parenthesis, patients with positive histology and no culture. 
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with Aspergillus (seven invasive disease, three aspergil- 
lomas), the case-definition ratio was >0.3 for all of 
them and > 0.5 for seven of them. 
For the 42 patients with positive cultures for 
Aspergillus sp. from LRTS, medical consultation or 
hospitalization was mainly related to pulmonary 
involvement, as suggested by the clinical presentation: 
93% reported cough, 73% dyspnoea, 70% productive 
sputum, 63% tachypnea and 42% fever. Forty-four 
percent of all patients were pensioners, 14% worked in 
building sites, 9% were housewives and 7% were 
disabled. Three main reasons led to culture of a lower 
respiratory tract specimen: dyspnoea (22%), lung 
infiltrate with fever (16%) and part of a general 
assessment (19%). In the latter group, all patients were 
classified as colonized (ratio 5 0.3). 
Among the 42 patients, seven suffered from AIDS. 
None were classified as cases of aspergillosis, two were 
in the undetermined group and five in the colonization 
group. All seven patients had advanced HIV-related 
disease with severe weight loss. This explains the low 
mean weight and body mass index (BMI) of the 
patients in the colonization and undetermined groups 
(mean weight 45.6 kg), which were significantly lower 
than in the aspergillosis patients. None of the HIV- 
infected patients presented clinically as invasive pul- 
monary aspergillosis or as aspergillosis related tracheitis 
and in no case did recovery of Aspergillus from culture 
have a clinical impact. Another respiratory pathogen 
(S .  pneumoniae, J? aeruginosa, S. maltophilia, E. coli and 
Acinetobacter sp.) was isolated from LRTS of five of 
them. 
Compared to those from patients considered to be 
colonized, cultures of LRTS from patients with proven 
or probable pulmonary aspergillosis showed a sig- 
nificant difference in the total number of Aspergillus 
colonies recovered from culture per episode, but not in 
delayed growth, mean number of positive samples and 
the proportion of agar plates positive for Aspergillus 
(Table 3). More than three coloniedagar plate and/or 
more than a total of twenty colonies recovered upon 
culture per episode could be used as cut-off for clinical 
significance. Indeed, 40% of the patients in the 
probable or proven aspergillosis group had more than 
three colonies/plate and a total of more than twenty 
colonies compared to 4% and 0% respectively, in the 
colonization group. One patient with values above the 
cut-off in the undetermined significance group, was 
suffering from allergic bronchopulmonary aspergillosis 
with extrinsic asthma. The mean number of colonies 
per positive specimen could also be used as cut-off for 
clinical significance. Indeed, more than 20 colonies 
were recovered per specimen from 25% of patients in 
the aspergillosis group and no patients in both the other 
groups (p=0.03). For bronchoalveolar lavage only, the 
mean number of Aspergillus coloniedagar plate was also 
significantly higher in the aspergillosis group. Overall, 
the sensitivity and specificity of Aspergillus sp. detection 
by culture in LRTS for proven or probable pulmonary 
aspergillosis was thus 35.7% and 70.4%, respectively. 
When comparing patients with proven or probable 
pulmonary aspergillosis with those considered to be 
colonized, the clinical impact of Aspergillus culture 
results as well as the presence of any comment on 
Aspergillus culture results in the medical chart and the 
introduction of anti-Aspergillus treatment were all 
significantly different (p<0.05) .  The impact of a 
positive culture result for Axpergillus was either a 
consultation by the infectious disease specialist (two 
occasions), additional LRTS (three times), measure- 
ment of anti-Aspergillus IgE (two cases) and/or the 
introduction of antifungal treatment (three times). A 
comment on the positive culture results for Aspergillus 
was found only 11 times in 42 medical files. The 
laboratory sheet with the culture result was missing 
from four fdes. The rather low impact of the culture 
results was partially due to the delay in requesting 
culture and delay in growth of the Aspergillus colonies; 
Table 3 Comparison of microbiological culture results for LRTS 
AspergiUosis Undetermined Colonized 
group (n=8)  group (n = 8) group (n=26) p value' 
Mean number of Aspergillus colonies/episode 
Mean number of Aspergillus colonies/agar plate: 
15.4 
- all specimens (n=205) 1.73 
- bronchoalveolar lavage (n=20) 2.34 
- sputum (n=147) 1.76 
Delay in growth (days) 2.4 
8.0 
0.94 
0.30 
1.31 
3.4 
5.1 0.022 
1.07 NS 
0.28 0.024 
1.14 NS 
2.5 NS 
Mean number of positive samples per patient 1.9 1.8 1.3 NS 
Proportion of pocitive samples 36% 31% 29% NS 
(Positive samples/Total number of samples) (15/42) (15/48) (34/115) 
'Aspergillosis group versus colonized patients. 
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results were obtained after the death of the patient in 
two instances and after the patient’s discharge from 
hospital in 13 cases. 
DISCUSSION 
Isolation of Aspegillus species from LRTS 1s not rare; 
occurring once to twice a week in our clinical 
microbiology laboratory serving an 800 bed general 
hospital. Aspergillus furn@ztus was the most frequent 
species of Aspeyillus isolated from LRTS. Except for 
cystic fibrosis patients, where the presence of Aspetgillus 
generally represents an allergic bronchopulmonary 
manifestation best treated with steroids [22], inter- 
preting the presence of Aspegi l lus  in LRTS is a 
challenge for both microbiologists and clinicians. Only 
10% of patients from whom Aspetgillus sp. was isolated 
had significant Aspegillrrr related respiratory disease and 
thus could benefit from antifungal treatment. The 
remaining 90% of patients from whom Aspevgillus 
sp. was isolated had non-significant respiratory tract 
colonization; it is thus of prime importance to correctly 
interpret Aspeyi l lus  culture results. 
The immune status of the patient is known to be 
the most important determinant in interpreting the 
clinical significance of growing Aspeyi l lus  from LRTS. 
Indeed, the risk of fungal infection increases as the 
neutrophil count decreases [23,24] and use of OKT3 
and/or high-dose corticosteroids predisposes to 
invasive disease [2S,26]. 
In spite of the limitations of a retrospective study, 
the case-definition ratio used here seems useful for 
interpreting the clinical significance of Aspeyi l lus  
isolated from LKTS. Indeed, it correlated with 
histological proof of aspergillosis when available. The 
case-definition ratio will be further validated in a 
prospective study. Such validation is difficult as the 
definitive gold-standard - positive histology associated 
with a positive culture - is only rarely available. More- 
over, Aspevgillus isolation from blood cultures, which is 
highly suggestive of invasive disease, is exceptional and 
no Aspergillus were isolated from blood culture in our 
laboratory during the one year study period. New 
specific serological tests and molecular amplification 
techniques [27,28], could be linked to such scoring 
y m m i s  in the future. 
Since neutropenic or highly immunosuppressed 
patients are at  high risk of invasive aspergillosis, this 
diagnosis was often considered in this context, but 
careful interpretation should also be undertaken in 
non-immunosuppressed patients and in HIV-infected 
patients. Several criteria including the presence of fever, 
cough, dyspnoea, chest X-ray infiltrate, steroid treat- 
ment and failure to respond to antibiotic therapy should 
be considered. The halo sign, target sign and bell-like 
image have been described as specific for the diagnosis 
of invasive aspergillosis and aspergilloma respectively 
[19-21,291. Though included in the case-definition 
questionnaire, these typical radiographic signs were not 
observed frequently, due to the low number of patients 
with clinically significant aspergillosis and the low rate 
of computerized tomography or magnetic resonance 
imaging performed in these patients. 
In HIV-infected patients, additional criteria of 
invasive disease have been established, such as a C134 
cell count below S0/mm3 , a history of pneumonia in 
the previous year and established AIDS, but these 
factors have not been correlated with more classical risk 
factors such as neutropenia or steroid treatment 
[30-32]. The difficulty of diagnosing significant 
Aspeyi l lus  disease in this setting is illustrated by an 
important antemorten underestimation of invasive 
aspergillosis. Indeed, up to 29% of cases were diagnosed 
at autopsy in some series 1121. As histology is rarely 
available in severely ill patients. a fungal culture of 
bronchoalveolar lavage fluid seems to be the method of 
choice for diagnosis [30]. In our study the low number 
of HIV-infected patients and the absence of probable 
aspergillosis cases precluded any statistical correlation. 
However, no patients died in a one month follow-up 
period despite their not receiving treatment for 
Aspegi l lus ,  which suggests colonization compatible 
with the case-definition ratio. 
Semi-quantitative culture results from LKTS seems 
to be useful in differentiating proven or probable 
aspergillosis from cases of colonization. Based on our 
results, the total number of colonies/culture and - for 
bronchoalveolar lavage only - the mean number of 
Aspetgillus colonies/agar plate should be considered as 
predictive of significant disease. More than three 
colonies/agar plate, more than a total of twenty 
colonies/episode and/or more than a total of twenty 
colonies/positive culture were also suggestive of asper- 
gillosis. Nevertheless, as many as five of seven patients 
with histological evidence of invasive pulmonary 
aspergillosis had no Aspergillus isolated, an LKTS 
culture having been done for only one of them. In 
addition, the low sensitivity of culture for Aspe<@llns 
observed in our study (35.7%) was documented in 
another recent study in which three specimens were 
needed to detect A s p e ~ i l l u s  in >90% of patients with 
definite or probable invasive pulmonary aspergillosis 
[7]. This low sensitivity could be enhanced by 
increasing the number of specimens for culture and/or 
by using specific media. Indeed, the mean percentage 
of fungal cultures per patient (67%) was significantly 
greater than the mean percentage of routine cultures 
positive per patient (31%) [7]. Such specific media are 
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generally added only when the clinician specifically 
requests a fungal culture. In our study, no statistical 
difference in rate of culture requests was found when 
comparing aspergillosis and colonized patients, thus 
excluding a bias in the result of the total number of 
colonies/culture. 
The clinical impact of isolating Arpergillus from 
LRTS and the introduction of anti-Aspergillus treatment 
were positively correlated with aspergillosis according 
to the case-definition ratio. The overall low impact of 
the culture results was mainly due to the delay in 
requesting culture and the time necessary to obtain 
positive cultures; about 35% of the results became 
available after the death or discharge of the patients. In 
a recent study, positive cultures were late findings in 
many patients mostly due to late requests for culture; 
indeed, hemoptysis, pleuritic chest pain or pleural rub 
occurred a mean of 11.8 days before the first positive 
culture, while infiltrates occurred a mean of 8.8 days 
before the first positive culture [7].  The late isolation 
of Aspergillur in cases of invasive aspergillosis, often 
occurring after discharge from hospital or death, 
emphasizes the need for better tests, e.g. molecular 
amplification techniques or new serological methods. 
The limitations of these new methods are their 
specificity. Indeed, in positive cases, the differential 
diagnosis remains colonization versus aspergillus-related 
pulmonary disease. Currently available immunoassays, 
which detect anti-Aspergillus antibody production in 
‘immunocompetent’ chronically infected subjects are 
highly sensitive. Indeed, anti-Aspergillus antibodies are 
often present in sera from patients with allergic 
bronchopulmonary aspergillosis, aspergilloma and 
chronic necrotizing pulmonary aspergillosis [33] .  How- 
ever, chronically colonized subjects can present with 
false positive immunoassay results. 
In conclusion, whenever Aspegillus is isolated from 
LRTS, the case-definition ratio should be calculated 
and related to semi-quantitative microbiological data. 
Patients with a ratio < 0.3 and less than 20 colonies per 
specimen are presumed colonized. Patients with a ratio 
> 0.5 or with more than 20 colonies per LRTS should 
be considered as probably suffering from Aspegillus- 
related pulmonary disease and further investigated. 
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